We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSFL
3376
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$2K ﹤0.01%
100
-477
-83% -$11.2K
ANFI
3377
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$2K ﹤0.01%
+2,092
New +$2.49K
ONCE
3378
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2K ﹤0.01%
19
-414
-96% -$44.7K
LTXB
3379
DELISTED
LegacyTexas Financial Group Inc
LTXB
$2K ﹤0.01%
49
+28
+133% +$1.1K
NRE
3380
DELISTED
NorthStar Realty Europe Corp.
NRE
$2K ﹤0.01%
121
-8,474
-99% -$144K
FRED
3381
DELISTED
Fred's Inc
FRED
$2K ﹤0.01%
3,456
-19,434
-85% -$18.8K
CTRL
3382
DELISTED
Control4 Corporation
CTRL
$2K ﹤0.01%
84
-2,240
-96% -$47K
CZFC
3383
DELISTED
Citizens First Corporation
CZFC
$2K ﹤0.01%
94
-18
-16% -$450
CIZ
3384
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
$2K ﹤0.01%
+62
New +$1.96K
ZIONW
3385
DELISTED
Zions Bancorporation N.A. Warrants
ZIONW
$2K ﹤0.01%
158
-1,600
-91% -$22.4K
KEM
3386
DELISTED
KEMET Corporation
KEM
$2K ﹤0.01%
101
-1,440
-93% -$25.2K
HIBB
3387
DELISTED
Hibbett, Inc. Common Stock
HIBB
$2K ﹤0.01%
100
+80
+400% +$1.68K
VVUS
3388
DELISTED
Vivus Inc
VVUS
$2K ﹤0.01%
533
-3,730
-87% -$13.7K
PLLL
3389
DELISTED
Piedmont Lithium Limited American Depositary Receipts
PLLL
$2K ﹤0.01%
+155
New +$2K
ABEV icon
3390
Ambev
ABEV
$46.4B
$1K ﹤0.01%
199
-63,990
-100% -$287K
ABR icon
3391
Arbor Realty Trust
ABR
$998M
$1K ﹤0.01%
100
-5,504
-98% -$71.5K
ACCO icon
3392
Acco Brands
ACCO
$407M
$1K ﹤0.01%
142
+17
+14% +$139
ACNT icon
3393
Ascent Industries
ACNT
$141M
$1K ﹤0.01%
36
-1,483
-98% -$25.5K
ADT icon
3394
ADT
ADT
$5.58B
$1K ﹤0.01%
211
-1,151
-85% -$7.33K
AEHR icon
3395
Aehr Test Systems
AEHR
$3.36B
$1K ﹤0.01%
454
-1,074
-70% -$1.77K
AGS
3396
DELISTED
PlayAGS
AGS
$1K ﹤0.01%
64
-167
-72% -$3.59K
AIRG icon
3397
Airgain
AIRG
$72.4M
$1K ﹤0.01%
100
+73
+270% +$1.05K
ALDX icon
3398
Aldeyra Therapeutics
ALDX
$93.5M
$1K ﹤0.01%
+199
New +$1.5K
ALLT icon
3399
Allot
ALLT
$383M
$1K ﹤0.01%
+138
New +$1.02K
ALV icon
3400
Autoliv
ALV
$9B
$1K ﹤0.01%
11
-2,430
-100% -$178K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.